Corporate Social Responsibility

Gilead Sciences Corporate Social Responsibility

Videos from this campaign

image from event
"The Centrifuge Sessions"
"Ranked "best" at ESG by patient advocacy groups"
scientist working
America's Most JUST Companies 2025 logo
"IDENTITY + INNOVATION"
D. Barry Crittenden
Cover of "The Adventure Jar" book
scientist working in a lab
Two people looking at a petri dish that one is holding up. "Seramount Inclusion Index 2024 Winner".

Content from this campaign

Diversity & Inclusion

Gilead Sciences Features Cristina Herrera of Translatinx Network
As we continue to celebrate Pride Month, we feature Cristina Herrera of Translatinx Network, a Gilead grantee.

Awards, Ratings & Rankings

Gilead Sciences is a Finalist for the PinkNews Awards in the Business Equality Category
We’re honored to be to be a finalist for the PinkNews Awards in the Business Equality category.

Diversity & Inclusion

Sara Tolaney on Gilead's Research Scholars Program and the Importance of Diversity in Medicine
Dr. Sara Tolaney oversees an independent and diverse scientific review committee composed of experts in oncology who review all applications and select who will receive funding. Diversity is at the forefront of her mind.

Awards, Ratings & Rankings

Michael Elliott Named to 2022 Empower Advocate Executive Role Model List.
Congratulations to Michael Elliott, Vice President of Development and Medical Affairs at Gilead, for being named to this year's Empower Advocate Executive Role Model List.

Health & Healthcare

Gilead Joining the Global Access to Oncology Medicines Coalition
We’re pleased to announce that we're joining the global Access to Oncology Medicines (ATOM) Coalition to help improve care and access to essential cancer medicines in low- and lower middle-income countries.

Philanthropy & Cause Initiatives

Gilead Reaches Number One Spot as Top Overall Philanthropic Funder of HIV-Related Programs, According to Funders Concerned About AIDS Report
“Gilead's support for community organizations is part of our enduring commitment to ending the HIV epidemic,” said Daniel O’Day, Chairman and Chief Executive Officer, Gilead Sciences.

Health & Healthcare

Gilead at Forefront of Herculean Effort to Combat COVID-19
Gilead scientists had planned for a moment like this through years of research. When coronaviruses with pandemic potential, like SARS and MERS, emerged in the early 2000s, Gilead began searching for potential new antivirals.

Health & Healthcare

Living with Metastatic Bladder Cancer: Joey's Journey
Watch Joey's story about living with Metastatic Bladder Cancer and his determination to beat it.

Diversity & Inclusion

Playwright Lee Raines Shines a Spotlight on the Criminalization of HIV
The day after Lee Raines found out he acquired HIV, he was arrested by police in New York.

Health & Healthcare

Gilead Sciences Presents at ECCMID 2022 - Continues Mission to Advance Access to Effective Therapies
The data we presented at ECCMID 2022 is part of Gilead’s mission to advance access to effective therapies.
Gilead Sciences

More from Gilead Sciences

  1. Corporate Social Responsibility
    Gilead Sciences Corporate Social Responsibility

  2. Age Positively
    Those who experienced the early days of the HIV/AIDS epidemic remember the generation we lost and the enduring impact that has had on our community...

  3. Gilead 2015 CSR Report
    Gilead’s Corporate Social Responsibility (CSR) Report provides an overview of the work the company is doing around the world to improve the lives of...